你即將離開本站

並前往https://ir.revmed.com/news-releases/news-release-details/revolution-medicines-reports-preclinical-tumor-regressions/

Press Release - Investor Relations | Revolution Medicines, Inc.

This first public disclosure of results showing anti-tumor activity for potent inhibitors of the notorious KRASG12D (ON) cancer protein was made ...

確定！ 回上一頁

查詢 「KRAS G12D」的人也找了：

  1. KRAS G12D inhibitor
    2.
  2. kras基因
    3.
  3. Sotorasib
    4.
  4. kras是什麼
    5.
  5. KRAS G12C
    6.
  6. KRAS mutation
    7.
  7. KRAS G12D lung cancer
    8.
  8. kras突變
    9.